The Lung Health Institute Educates the Public on the Restorative Nature of Regenerative Medicine in Support of Healthy Lung Month
Tampa, Fla. (October 30, 2013) – Regenerative medicine is the latest medical technology for the promotion of healing of lung tissue affected by lung disease. The Lung Health Institute’s physicians have harnessed this advancement in modern medicine to bring patients with conditions like chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, chronic bronchitis and emphysema an innovative treatment choice that betters their quality of life and helps them to breathe easier.
Often, many of these patients have been told that lung transplantation is their only option, and as a result many are turning to advanced treatments such as pulmonary cellular therapies to enhance lung function and promote healing. Here’s some information about how Cellular Therapies as Alternative to Lung Transplantation could be beneficial for people with chronic lung diseases.
How do Cells Help Damaged Lung Tissue?
The Lung Health Institute utilizes autologous cells, meaning those derived from the patient’s own blood, for treatment.
Both cellular therapies and lung transplantation have been proven, in many cases, to improve quality of life. However, lung transplantation is an invasive inpatient surgery that has far riskier complications and a longer recovery time.
About Lung Health Institute
The Lung Health Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Health Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com/dev or call 888-745-6697.